MedPath

Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

Not Applicable
Active, not recruiting
Conditions
Breast Cancer Female
Sexual Dysfunction
Interventions
Other: Educational video series
Registration Number
NCT06121258
Lead Sponsor
University of Colorado, Denver
Brief Summary

The purpose of this study is to assess the acceptability, appropriateness, and feasibility of a educational video series for patients going through breast cancer treatment.

Detailed Description

This is a prospective, mixed methods pilot study to evaluate the acceptability, appropriateness, and feasibility of a novel educational video series for patients going through breast cancer treatment. The video series addresses topics such as what to expect from breast surgery, how to prepare for breast surgery, treatment effects of breast cancer therapies, and mitigation and communication strategies for navigating breast cancer treatment.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Stage I-III invasive breast cancer within one month of initial multi-disciplinary clinic visit or surgical consultation
  • Ability to complete survey material independently
  • Able to read and speak English
  • Willingness to comply with study material and procedures
Read More
Exclusion Criteria
  • Age < 18 years old
  • Stage 0 or IV breast cancer
  • Non-breast cancer diagnoses
  • History of anti-hormonal therapy, chemotherapy, or radiotherapy not related to breast cancer
  • Prior breast cancer diagnosis
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Video website accessEducational video seriesParticipants will gain access to the educational video website in order to watch the series.
Primary Outcome Measures
NameTimeMethod
Acceptability of the educational video series after six-months of access and use by breast cancer patients as measured by AIM instrument.6 months

The Acceptability of Intervention Measure (AIM) is a validated instrument used to measure the acceptability of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater acceptability).

Appropriateness of the educational video series after six-months of access and use by breast cancer patients as measured by IAM instrument.6 months

The Intervention Appropriateness Measure (IAM) is a validated instrument used to measure the appropriateness of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater appropriateness).

Determine the sustainability of the educational video series after six-months of access and use by breast cancer patients as measured by the FIM instrument.6 months

The Feasibility of Intervention Measure (FIM) is a validated instrument used to measure the feasibility, or sustainability, of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater feasibility).

Secondary Outcome Measures
NameTimeMethod
Change from baseline in sexual health and function at six-months, as measured by the PROMIS Sexual Function v2 Brief Profile (Female)Baseline, 6 months

The Patient-Reported Outcomes Measurement Information System (PROMIS) Sexual Function v2 Brief Profile (Female) is a well-validated tool in oncology patients to assess sexual health. Calibrated subdomain scores are expressed as T-scores (mean=50, standard deviation=10). A T-score 50 corresponds to the mean response among cancer survivors used for previous item testing. Higher scores indicate better outcomes within the domain. We will assess the change at 6 months from baseline.

Trial Locations

Locations (1)

University of Colorado Health

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath